Advertisement Pfizer to pay $10m over Prempro dispute - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Pfizer to pay $10m over Prempro dispute

Pfizer will have to pay more than $10m as damages to Arkansas-based Mary Daniel after an appeals court reinstated a jury verdict.

Daniel had blamed the company for getting breast cancer after taking its Prempro menopause drug, bloomberg.com reported.

A Pennsylvania appeals court overturned a ruling that Pfizer’s Wyeth unit should have a new trial related to Daniel’s claim (A Philadelphia jury had awarded Daniel and her family $1.5m in compensatory damages and $8.6 million in punitives in 2007).

Officials of the New York-based Pfizer said they were disappointed with the decision and considering their legal options.

Bloomberg.com has quoted Pfizer spokesman Christopher Loder as saying that the company disputes the fairness of the previous trial and the appropriateness of the jury’s verdict.